Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: A systematic review and meta-analysis of observational studies

Circulation

Volumn 121, Issue 16, 2010, Pages 1838-1847

  Kenet, Gili ^a   Lütkhoff, Lisa K ^b   Albisetti, Manuela ^c   Bernard, Timothy ^d   Bonduel, Mariana ^e   Brandao, Leonardo ^f   Chabrier, Stephane ^g   Chan, Anthony ^h   Deveber, Gabrielle ^f   Fiedler, Barbara ^b   Fullerton, Heather J ⁱ   Goldenberg, Neil A ^d   Grabowski, Eric ^j   Günther, Gudrun ^k   Heller, Christine ^l   Holzhauer, Susanne ^m   Iorio, Alfonso ⁿ   Journeycake, Janna ^o   Junker, Ralf ^p   Kirkham, Fenella J ^q,r   Kurnik, Karin ^s   Lynch, John K ^t   Male, Christoph ^u   Manco Johnson, Marilyn ^d   Mesters, Rolf ^b   Monagle, Paul ^v   Van Ommen, C Heleen ^w   Raffini, Leslie ^x   Rostásy, Kevin ^y   Simioni, Paolo ^z   Sträter, Ronald D ^b   Young, Guy ^aa   Nowak Göttl, Ulrike ^b   more..

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d Children's Hospital Colorado   (United States)

^e HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

^k UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^l UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^m CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁿ UNIVERSITY OF PERUGIA   (Italy)

^o UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^p UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^q UNIVERSITY COLLEGE LONDON   (United Kingdom)

^r SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^s LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^t NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^u MEDICAL UNIVERSITY OF VIENNA   (Austria)

^v ROYAL CHILDREN'S HOSPITAL   (Australia)

^w EMMA CHILDREN S HOSPITAL   (Netherlands)

^x UNIVERSITY OF PENNSYLVANIA   (United States)

^y INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^z UNIVERSITY OF PADOVA   (Italy)

^aa CHILDREN S HOSPITAL LOS ANGELES   (United States)

more..

Author keywords

Cerebrovascular disorders; Meta analysis; Pediatrics; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN;

ANTITHROMBIN DEFICIENCY; ARTICLE; CEREBRAL SINUS THROMBOSIS; CEREBROVASCULAR ACCIDENT; CHILD; ETHNICITY; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK ASSESSMENT; STROKE; SYSTEMATIC REVIEW; THROMBOPHILIA;

BRAIN ISCHEMIA; CHILD; HUMANS; INFANT, NEWBORN; RISK FACTORS; SINUS THROMBOSIS, INTRACRANIAL; STROKE; THROMBOPHILIA;

EID: 77951767998     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.913673     Document Type: Article

References (92)

1. Lynch JK, Hirtz DG, deVeber G, Nelson K. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics. 2002;109:116-123. (Pubitemid 34049435)
2. DeVeber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, Camfield CS, David M, Humphreys P, Langevin P, MacDonald AE, Gillett J, Meaney B, Shevell M, Sinclair DB, Yager J, for the Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345:417-423.
3. Kleindorfer D, Khoury J, Kissela B, Alwell K, Woo D, Miller R, Schneider A, Moomaw C, Broderick JP. Temporal trends in the incidence and case fatality of stroke in children and adolescents. J Child Neurol. 2006;21:415-418. (Pubitemid 44057061)
4. Lanthier S, Carmant L, David M, Larbrisseau A, deVeber G. Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology. 2000;54:371-378. (Pubitemid 30078068)
5. Kenet G, Sadetzki S, Murad H, Martinowitz U, Rosenberg N, Gitel S, Rechavi G, Inbal A. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke. 2000;31: 1283-1288. (Pubitemid 30351246)
6. Berkun Y, Padeh S, Barash J, Uziel Y, Harel L, Mukamel M, Revel-Vilk S, Kenet G. Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum. 2006;55:850-855. (Pubitemid 44917456)
7. Uysal S, Anlar B, Altay C, Kirazli S. Role of protein C in childhood cerebrovascular occlusive accidents. Eur J Pediatr. 1989;149:216-218. (Pubitemid 20015194)
8. Kennedy CR, Warner G, Kai M, Chisholm M. Protein C deficiency and stroke in early life. Dev Med Child Neurol. 1995;37:723-730.
9. Riikonen RS, Vahtera EM, Kekomäki RM. Physiological anticoagulants and activated protein C resistance in childhood stroke. Acta Paediatr. 1996;85:242-244. (Pubitemid 26063663)
10. Koh S, Chen LS. Protein C and S deficiency in children with ischemic cerebrovascular accident. Pediatr Neurol. 1997;17:319-321. (Pubitemid 28018861)
11. Ganesan V, McShane MA, Liesner R, Cookson J, Hann I, Kirkham FJ. Inherited prothrombotic states and ischaemic stroke in childhood. J Neurol Neurosurg Psychiatry. 1998;65:508-511. (Pubitemid 28438881)
12. Becker S, Heller C, Gropp F, Scharrer I, Kreuz W. Thrombophilic disorders in children with cerebral infarction. Lancet. 1998;352: 1756-1757. (Pubitemid 28534967)
13. Zenz W, Bodó Z, Plotho J, Streif W, Male C, Bernert G, Rauter L, Ebetsberger G, Kaltenbrunner K, Kurnik P, Lischka A, Paky F, Ploier R, Höfler G, Mannhalter C, Muntean W. Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke. Thromb Haemost. 1998;80:763-766. (Pubitemid 28521719)
14. Mohanty S, Saxena R, Behari M. Activated protein C (APC) resistance in young stroke patients. Thromb Haemost. 1999;81:465-466. (Pubitemid 29116624)
15. Akar N, Akar E, Deda G, Sipahi T, Orsal A. Factor V1691 G-A, pro-thrombin 20210 G-A, and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct. J Child Neurol. 1999; 14:749-751.
16. Heller C, Becker S, Scharrer I, Kreuz W. Prothrombotic risk factors in childhood stroke and venous thrombosis. Eur J Pediatr. 1999;158(suppl 3):S117-S121. (Pubitemid 30014016)
17. McColl MD, Chalmers EA, Thomas A, Sproul A, Healey C, Rafferty I, McWilliam R, Eunson P. Factor V Leiden, prothrombin 20210G-A and the MTHFR C677T mutations in childhood stroke. Thromb Haemost. 1999;81:690-694.
18. Nowak-Göttl U, Sträter R, Heinecke A, Junker R, Koch HG, Schuierer G, von Eckardstein A. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood. 1999;94: 3678-3682.
19. Sträter R, Vielhaber H, Kassenböhmer R, von Kries R, Göbel U, Nowak-Göttl U. Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin: a prospective ESPED survey. Eur J Pediatr. 1999;158(suppl 3):S122-S125. (Pubitemid 30014017)
20. Günther G, Junker R, Sträter R, Schobess R, Kurnik K, Heller C, Kosch A, Nowak-Göttl U, for the Childhood Stroke Study Group. Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic pro-thrombotic risk factors. Stroke. 2000;31:2437-2441.
21. Cardo E, Monrós E, Colomé C, Artuch R, Campistol J, Pineda M, Vilaseca MA. Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status. J Child Neurol. 2000; 15:295-298. (Pubitemid 30341360)
22. Akar N, Akar E, Ozel D, Deda G, Sipahi T. Common mutations at the homocysteine metabolism pathway and pediatric stroke. Thromb Res. 2001;102:115-120. (Pubitemid 32373220)
23. Mercuri E, Cowan F, Gupte G, Manning R, Laffan M, Rutherford M, Edwards AD, Dubowitz L, Roberts I. Prothrombotic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarction. Pediatrics. 2001;107:1400-1404. (Pubitemid 32525223)
24. Barreirinho S, Ferro A, Santos M, Costa E, Pinto-Basto J, Sousa A, Sequeiros J, Maciel P, Barbot C, Barbot J. Inherited and acquired risk factors and their combined effects in pediatric stroke. Pediatr Neurol. 2003;28:134-138. (Pubitemid 36434160)
25. Bonduel M, Sciuccati G. Hepner M, Pieroni G, Torres AF, Mardaraz C, Frontroth JP. Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism. Am J Hematol. 2003;73: 81-86. (Pubitemid 36578428)
26. Ganesan V, Prengler M, McShane MA, Wade AM, Kirkham FJ. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol. 2003;53:167-173. (Pubitemid 36163997)
27. Kurnik K, Kosch A, Sträter R, Schobess R, Heller C, Nowak-Göttl U. Recurrent thromboembolism in infants and children suffering from symptomatic neonatal arterial stroke: a prospective follow-up study. Stroke. 2003;34:2887-2892. (Pubitemid 37517762)
28. Barnes C, Newall F, Harvey AS, Monagle P. Thrombophilia interpretation in childhood stroke: a cautionary tale. J Child Neurol. 2004;19: 218-219. (Pubitemid 38559714)
29. Chung B, Wong V. Pediatric stroke among Hong Kong Chinese subjects. Pediatrics. 2004;114:e206-e212.
30. Debus OM, Kosch A, Sträter R, Rossi R, Nowak-Göttl U. The factor V G1691A mutation is a risk for porencephaly: a case-control study. Ann Neurol. 2004;56:287-290. (Pubitemid 39037925)
31. Duran R, Biner B, Demir M, Celtik C, Karasalihoglu S. Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke. Clin Appl Thromb Hemost. 2005;11:83-88. (Pubitemid 40194202)
32. Lynch JK, Han CJ, Nee LE, Nelson KB. Prothrombotic factors in children with stroke or porencephaly. Pediatrics. 2005;116:447-453.
33. Bonduel M, Sciuccati G, Hepner M, Pieroni G, Torres AF, Frontroth JP, Tenembaum S. Arterial ischemic stroke and cerebral venous thrombosis in children: a 12-year Argentinean registry. Acta Haematol. 2006;115: 180-185.
34. Komitopoulou A, Platokouki H, Kapsimali Z, Pergantou H, Adamtziki E, Aronis S. Mutations and polymorphisms in genes affecting hemostasis proteins and homocysteine metabolism in children with arterial ischemic stroke. Cerebrovasc Dis. 2006;22:13-20. (Pubitemid 43875155)
35. Simchen MJ, Goldstein G, Lubetsky A, Strauss T, Schiff E, Kenet G. Factor V Leiden and antiphospholipid antibodies in either mothers or infants increase the risk for perinatal arterial ischemic stroke. Stroke. 2009;40:65-70.
36. Del Balzo F, Spalice A, Ruggieri M, Greco F, Properzi E, Iannetti P. Stroke in children: inherited and acquired factors and age-related variations in the presentation of 48 paediatric patients. Acta Paediatr. 2009; 98:1130-1136
37. deVeber G, Monagle P, Chan A, MacGregor D, Curtis R, Lee S, Vegh P, Adams M, Marzinotto V, Leaker M, Massicotte P, Lillicrap D, Andrew M. Prothrombotic disorders in infants and children with cerebral throm-boembolism. Arch Neurol. 1998;55:1539-1543. (Pubitemid 28566623)
38. Vielhaber H, Ehrenforth S, Koch HG, Scharrer I, van der Werf N, Nowak-Göttl U. Cerebral venous thrombosis in infancy and childhood: role of genetic and acquired risk factors of thrombophilia. Eur J Pediatr. 1998;157:555-560. (Pubitemid 28311481)
39. Bonduel M, Sciuccati G, Hepner M, Torres AF, Pieroni G, Frontroth JP. Prothrombotic disorders in children with arterial ischemic stroke and sinovenous thrombosis. Arch Neurol. 1999;56:967-971. (Pubitemid 29374814)
40. Ehrenforth S, Junker R, Koch HG, Kreuz W, Münchow N, Scharrer I, Nowak-Göttl U. Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood: Childhood Throm-bophilia Study Group. Eur J Pediatr. 1999;158:S97-S104.
41. Junker R, Koch HG, Auberger K, Münchow N, Ehrenforth S, Nowak-Göttl U. Prothrombin G20210A gene mutation and further pro-thrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol. 1999;19:2568-2572. (Pubitemid 29477861)
42. Nowak-Göttl U, Junker R, Hartmeier M, Koch HG, Münchow N, Assmann G, von Eckardstein A. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in Childhood. Circulation. 1999a;100:743-748. (Pubitemid 29383645)
43. Bonduel M, Hepner M, Sciuccati G, Pieroni G, Feliú-Torres A, Mardaraz C, Frontroth JP. Factor V Leiden and prothrombin gene G20210A mutation in children with venous thromboembolism. Thromb Haemost. 2002;87:972-977. (Pubitemid 34624878)
44. Heller C, Heinecke A, Junker R, Knöfler R, Kosch A, Kurnik K, Schobess R, von Eckardstein A, Sträter R, Zieger B, Nowak-Göttl U, for the Childhood Stroke Study Group. Cerebral venous thrombosis in children: a multifactorial origin. Circulation. 2003;108:1362-1367. (Pubitemid 37174415)
45. Young G, Manco-Johnson M, Gill JC, Dimichele DM, Tarantino MD, Abshire T, Nugent DJ. Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study. J Thromb Haemost. 2003;1:958-962.
46. Gürgey A, Balta G, Gumruk F, Altay C. Analysis of some clinical and laboratory aspects of adolescent patients with thrombosis. Blood Coagul Fibrinolysis. 2004;15:657-662. (Pubitemid 39612971)
47. Kenet G, Waldman D, Lubetsky A, Kornbrut N, Khalil A, Koren A, Wolach B, Fattal A, Kapelushnik J, Tamary H, Yacobovitch J, Raveh E, Revel-Vilk S, Toren A, Brenner B. Paediatric cerebral sinus vein thrombosis: a multi-center, case-controlled study. Thromb Haemost. 2004;92: 713-718. (Pubitemid 39386695)
48. Sébire G, Tabarki B, Saunders DE, Leroy I, Liesner R, Saint-Martin C, Husson B, Williams AN, Wade A, Kirkham FJ. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain. 2005;128:477-489. (Pubitemid 40380184)
49. Komitopoulou A, Platokouki H, Kapsimali Z, Moschovi M, Kattamis A. Mutations and polymorphisms in genes affecting haemostasis components in children with thromboembolic events. Pathophysiol Haemost Thromb. 2006;35:392-397. (Pubitemid 46141171)
50. Kenet G, Kirkham F, Niederstadt T, Heinecke A, Saunders D, Stoll M, Brenner B, Bidlingmaier C, Heller C, Knöfler R, Schobess R, Zieger B, Sébire G, Nowak-Göttl U, for the European Thromboses Study Group. Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a mul-ticentre cohort study. Lancet Neurol. 2007;6:595-603. (Pubitemid 46921043)
51. Gentilomo C, Franzoi M, Laverda AM, Suppiej A, Battistella PA, Simioni P. Cerebral sinovenous thrombosis in children: thrombophilia and clinical outcome. Thromb Res. 2008;121:589-591. (Pubitemid 351174275)
52. Ozyurek E, Balta G, Degerliyurt A, Parlak H, Aysun S, Gürgey A. Significance of factor V, prothrombin, MTHFR, and PAI-1 genotypes in childhood cerebral thrombosis. Clin Appl Thromb Hemost. 2007;13: 154-160. (Pubitemid 46548366)
53. Prengler M, Sturt N, Krywawych S, Surtees R, Liesner R, Kirkham F. Homozygous thermolabile variant of the methylenetetrahydrofolate reductase gene: a potential risk factor for hyperhomocysteinaemia, CVD, and stroke in childhood. Dev Med Child Neurol. 2001;43:220-225. (Pubitemid 32328195)
54. Kosch A, Koch HG, Heinecke A, Kurnik K, Heller C, Nowak-Göttl U. Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children. Thromb Haemost. 1004;91:308-314.
55. van Beynum IM, Smeitink JA, den Heijer M, te Poele Pothoff MT, Blom HJ. Hyperhomocysteinemia: a risk factor for ischemic stroke in children. Circulation. 1999;27;99:2070-2072. (Pubitemid 29196787)
56. Varga EA, Sturm AC, Misita CP, Moll S. Homocysteine and MTHFR mutations. Circulation. 2005;111:e289-e293.
57. Nowak-Göttl U, Langer C, Bergs S, Thedieck S, Sträter R, Stoll M. Genetics of hemostasis: differential effects of heritability and household components influencing lipid concentrations and clotting factor levels in 282 pediatric stroke families. Environ Health Perspect. 2008;116: 839-843. (Pubitemid 351943943)
58. Miller SP, Wu YW, Lee J, Lammer EJ, Iovannisci DM, Glidden DV, Bonifacio SL, Collins A, Shaw GM, Barkovich AJ, Ferriero DM. Candidate gene polymorphisms do not differ between newborns with stroke and normal controls. Stroke. 2006;37:2678-2683. (Pubitemid 44922525)
59. Nowak-Göttl U, Fröhlich B, Thedieck S, Huge A, Stoll M. Association of the protein Z ATG haplotype with symptomatic nonvascular stroke or thromboembolism in white children: a family-based cohort study. Blood. 2009;113:2336-2341.
60. Nowak-Göttl U, Weiler H, Hernandez I, Thedieck S, Seehafer T, Schulte T, Stoll M. Fibrinogen alpha and gamma genes and factor V Leiden in children with thromboembolism: results from 2 family-based association studies. Blood. 2009;114:1947-1953.
61. Tormene D, Gavasso S, Rossetto V, Simioni P. Thrombosis and throm-bophilia in children: a systematic review. Semin Thromb Hemost. 2006; 32:724-728. (Pubitemid 44623380)
62. Tormene D, Simioni P, Prandoni P, Franz F, Zerbinati P, Tognin G, Girolami A. The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. Blood. 2002;100:2403-2405.
63. Sass AE, Neufeld EJ. Risk factors for thromboembolism teens: when should I test? Cur Opin Pediatr. 2002;14:370-378.
64. Wiliams MD, Chalmers E, Gibson BES. Guideline: the investigation and management of neonatal haemostasis and thrombosis. Br J Haematol. 2002;119:295-309. (Pubitemid 35365475)
65. Ruud E, Holmström H, Brosstad F, Wesenberg F. Diagnostic value of family histories of thrombosis to identify children with thrombophilia. Pediatr Hematol Oncol. 2005;22:453-462. (Pubitemid 41285879)
66. Johal SC, Garg BP, Heiny ME, LS, Saha C, Walsh LE, Golomb MR. Family history is a poor screen for prothrombotic genes in children with stroke. J Pediatr. 2006;148:68-71.
67. Dietrich JE, Hertweck SP, Perlman SE. Efficacy of family history in determining thrombophilia risk. J Pediatr Adolesc Gynecol. 2007;20:221-224. (Pubitemid 47126328)
68. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000; 283:2008-2012. (Pubitemid 30214957)
69. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M, for the STROBE Initiative. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007; 147:W163-W194. (Pubitemid 351664503)
70. Mayer D. Essential Evidence-Based Medicine. Boston, Mass: Cambridge University Press; 2004:347-360.
71. Kirkwood BR, Sterne JAC. Medical Statistics. 2nd ed. Boston, Mass: Blackwell Science; 2003:180-387.
72. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ. 2003;327:557-560.
73. Harbord RM, Egger M, Sterne JAC. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25:3443-3457. (Pubitemid 44575162)
74. Caruso V, Iacoviello L, Di Castelnuovo A, Storti S, Mariani G, de Gaetano G, Donati MB. Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood. 2006;108:2216-2222. (Pubitemid 44497502)
75. Young G, Albisetti M, Bonduel M, Brandao L, Chan A, Friedrichs F, Goldenberg NA, Grabowski E, Heller C, Journeycake J, Kenet G, Krümpel A, Kurnik K, Lubetsky A, Male C, Manco-Johnson M, Mathew P, Monagle P, van Ommen H, Simioni P, Svirin P, Tormene D, Nowak-Göttl U. Impact of inherited thrombophilia on venous thrombo-embolism in children: a systematic review and meta-analysis of observational studies. Circulation. 2008;118:1373-1382.
76. Haywood S, Liesner R, Pindora S, Ganesan V. Thrombophilia and first arterial ischaemic stroke: a systematic review. Arch Dis Child. 2005;90: 402-405. (Pubitemid 40488681)
77. Smolders B, Lemmens R, Thijs V. Lipoprotein (a) and stroke: a meta-analysis of observational studies. Stroke. 2007;38:1959-1966. (Pubitemid 46847277)
78. Emerging Risk Factors Collaboration, Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J. Lipoprotein (a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009; 302:412-423.
79. Sofi F, Marcucci R, Abbate R, Gensini GF, Prisco D. Lipoprotein (a) and venous thrombosis in adults: a meta-analysis. Am J Med. 2007;120: 728-733. (Pubitemid 47189658)
80. Hancock MA, Boffa MB, Marcovina SM, Nesheim ME, Koschinsky ML. Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces. J Biol Chem. 2003;287:23260-23269.
81. Lynch JK, Nelson KB. Epidemiology of perinatal stroke. Curr Opin Pediatr. 2001;13:499-505.
82. Chalmers EA. Perinatal stroke: risk factors and management. Br J Haematol. 2005;130:333-343. (Pubitemid 43899582)
83. Golomb MR, MacGregor DL, Domi T, Armstrong DC, McCrindle BW, Mayank S, deVeber GA. Presumed pre-or perinatal arterial ischemic stroke: risk factors and outcomes. Ann Neurol. 2001;50:163-168. (Pubitemid 32738140)
84. Lee J, Croen LA, Backstrand KH, Yoshida CK, Henning LH, Lindan C, Ferriero DM, Fullerton HJ, Barkovich AJ, Wu YW. Maternal and infant characteristics associated with perinatal arterial stroke in the infant. JAMA. 2005;293:723-729. (Pubitemid 40216042)
85. Golomb MR. The contribution of prothrombotic disorders to peri-and neonatal ischemic stroke. Semin Thromb Hemost. 2003;29:415-424.
86. Curry CJ, Bhullar S, Holmes J, Delozier CD, Roeder ER, Hutchison HT. Risk factors for perinatal arterial stroke: a study of 60 mother-child pairs. Pediatr Neurol. 2007;37:99-107. (Pubitemid 47187651)
87. Rees DC. The population genetics of factor V Leiden (Arg 506 Gln). Br J Haematol. 1996;95:579-586. (Pubitemid 26423357)
88. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost. 1998;79:706-708. (Pubitemid 28163839)
89. Pepe G, Rickards O, Vanegas OC, Brunelli T, Gori AM, Giusti B, Attanasio M, Prisco D, Gensini GF, Abbate R. Prevalence of factor V Leiden mutation in non-European populations. Thromb Haemost. 1997; 77:329-331. (Pubitemid 27084925)
90. Gürgey A, Mesci L. The prevalence of factor V Leiden (1691 G-A) mutation in Turkey. Turk J Pediatr. 1997;39:313-315. (Pubitemid 127562936)
91. Gürgey A, Hicsönmez G, Parlak H, Balta G, Celiker A. Prothrombin gene 20210 G-A mutation in Turkish patients with thrombosis. Am J Hematol. 1998;59:179-180.
92. Ganesan V, Prengler M, Wade A, Kirkham FJ. Clinical and radiological recurrence after childhood arterial ischemic stroke. Circulation. 2006;114:2170-2177. (Pubitemid 44747898)